Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Xalatan®
DRUG
3 trials
Sponsors
Alcon Research
, Shaare Zedek Medical Center
, Santen SAS
Conditions
Glaucoma
IOP
Ocular Hypertension
Ocular Surface Disease
Open-Angle Glaucoma or Ocular Hypertension
Phase 3
A Phase III Multinational Multicenter Investigator-Masked Randomized Active-Controlled Trial Comparing the Efficacy and Safety of DE-130A With Xalatan® in Patients With Open-Angle Glaucoma or Ocular Hypertension
Completed
NCT04133311
Santen SAS
Ocular Surface Disease, Open-Angle Glaucoma or Ocular Hypertension
Start: 2019-04-10
End: 2022-10-26
Updated: 2024-05-28
Phase 4
Short Term Comparative Study of Xalatan With Benzalkonium Chloride vs. Travatan Z Without Benzalkonium Chloride in Healthy Volunteers
Completed
NCT00468988
Alcon Research
Glaucoma
Start: 2007-05-31
End: 2007-07-31
Target: 30
Updated: 2012-05-25
Unknown Phase
Safety, Tolerability and Preliminary Efficacy of Unilateral Latanoprost-loaded Punctual Plug -EXP-LP
NCT03318146
Shaare Zedek Medical Center
Glaucoma, IOP, Ocular Hypertension
Start: 2018-06-01
End: 2019-09-01
Target: 40
Updated: 2017-11-28
Related Papers
A latanoprost cationic emulsion (STN1013001) vs. other latanoprost formulations (Latanoprost) in open angle glaucoma/ocular hypertension and ocular surface disease: an Italian cost-utility analysis
Expert Review of Pharmacoeconomics & Outcomes Research
2022-12-28
3 citations